For more details on the courses, please refer to the Course Catalog
| Code | Course Title | Credit | Learning Time | Division | Degree | Grade | Note | Language | Availability |
|---|---|---|---|---|---|---|---|---|---|
| CSP5011 | Seminars on the Clinical Drug Development | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The course is aiming to provide theory and skills in clinical drug research and to support students’ research progress thru team discussion and presentation. | |||||||||
| CSP5012 | Seminars on the Pharmacotherapy Research | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The course is aiming to provide theory and skills in pharmacotherapy research and to support students’ research progress thru team discussion and presentation. | |||||||||
| CSP5017 | Special Topics in Pharmaceutical Marketing Research | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course covers how to collect and analyze data on consumer perceptions, attitudes, and behaviors of pharmaceuticals for marketing decision making by pharmaceutical companies. This course deals with marketing research design, experimental design, hypothesis testing, and multivariate analysis techniques for pharmaceutical marketing research based on understanding consumer behaviors of pharmaceuticals. | |||||||||
| CSP5018 | Special Topics in Pharmaceutical Supply Chain | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course will cover the theoredical back ground of pharmaceutical distribution and deals with the educational Tool-kits for pharmaceutical supply chain which were developed by AHC(APEC Harmonization Center). This course covers global guidelines on pharmaceutical distribution management, track and trace for supply chain, Good Distribution Practice, etc | |||||||||
| CSP5025 | Evidence-based Pharmacy | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course will included the concept of evidence-based pharmacy, and pyramid of clinical study. The course will to understand each study design in clinical study, systematic review/meta-analysis, and decision-making in public health as well as pharmacy field. | |||||||||
| CSP5028 | Advanced Statistics in Pharmacy | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The course will cover the essential elements of statistical analysis plan and the concept of sample size estimation. The students will write a SAP using real-world example, and participate in presentation and discussion. Also, this course will include a concept of common data model, and understating of a distributed model focused on the longitudinal data analyses. | |||||||||
| CSP5030 | Pharmaceutical Care in Community | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The purpose of this course is understanding for the necessity, definition and methodology of community pharmacy. This course covered the basic public health, epidemiological approach for community health and pharmacy diagnosis, strategy for health promotion and rational drug utilization. This course provides the lecture, investigation the real case and discussion. | |||||||||
| CSP5031 | Pharmcy Management | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course deals with knowledge for effective pharmacy management based on basic theories of economics and business. This course covers pharmacy organization management including planning, organizing, staffing, directing and controlling. It also covers pharmaceutical system analysis; relationship between pharmaceutical management and organizational management. To equip with skills and insights for successful pharmacy marketing by combining general marketing frame and pharmacy market dynamics. The class will deal with introduction to marketing, pharmacy marketing processes and application of pharmacy marketing. | |||||||||
| CSP5033 | The Behavior in Social Pharmacy | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| Concepts related to the social and behavioral components of drug use is to be introduced. This course cover topics on diseases and illness, social construction of diagnosis, functions of drugs, prescribing and dispensing, compliance and non-compliance, consumer and patient behavior, self-care and self-medication, models in behavioral pharmacy. | |||||||||
| CSP5034 | Health Security Policy | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The goal of this course is understanding the classification and characteristic of health security and a status and task of health security in South Korea. The course provides critical understanding of the theory for health security system, the health security systems of developed countries, the coverage for pharmaceutical products through a lecture, investigation the real case and discussion. | |||||||||
| CSP5035 | Case Study on Phamaceutical Policy Issue | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| The purpose of this subject is to enable the development of the nation's pharmacy-related systems by understanding and comparing them with each other. To this end, we review the methodology of analysis of health care systems, including the number of pharmacy-related policies and institutions, and categorize the world system around several characteristics (human resources, facilities, funding systems, etc.). In particular, the role of public health in pharmacies is considered by area. | |||||||||
| CSP5036 | Pharmaceutical Communication | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course is designed to help students become effective counselors and advocates for patients healthcare professionals. This course covers presents communication concepts and skills, communication tools and practical exercises for applying the patients and other health professionals. | |||||||||
| CSP5038 | Studies on Innovative Biotherapeutics | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course is aimed (1) to understand science of innovative biotherapeutics including gene therapy, cell therapy, recombinant antibody products, recombinant protein products, vaccines, as well as targeted therapy. (2) to study related regulations and development guidelines (3) to be able to make development strategy for the innovative biotherapeutics. | |||||||||
| CSP5039 | Methods on Generating RWE for the evaluation of Drug Effectiveness | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course will cover generating real-world evidence (RWE) on drug effectiveness by using real-world data (RWD), which includes electronic medical records and common data models. This course will provide detailed knowledge on the considerations and the process of conducting the study, such as a single-arm trial or external comparator, which are newly developed and utilized in this field. | |||||||||
| CSP5040 | Seminars in Pharmacoepidemiology | 3 | 6 | Major | Master/Doctor | Clinical and Social Pharmacy | - | No | |
| This course is aimed to provide the considerations when conducting a pharmacoepidemiological study. The considerations will be divided into four parts (selection of study design, minimization of bias, study design-specific considerations, statistical analyses), and students will read at least 2 articles each week. Students will re-establish the fundamental knowledge in pharmacoepidemiology and enhance their ability to adapt to their researches | |||||||||